• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • NICE endorses Keytruda for bladder cancer pharmatimes
    March 19, 2018
    MSD’s Keytruda is the first and only immunotherapy to be recommended for NHS use to treat urothelial carcinoma patients, when prior platinum-containing chemotherapy fails.
  • Lilly's Cyramza combo boasts strong results in bladder cancer pharmafile
    September 12, 2017
    Eli Lilly has announced new Phase 3 data at the European Society for Medical Oncology 2017 Congress which further add to the efficacy profile of Cyramza in treating platinum-refractory advanced urothelial carcinoma when used in combination with docetaxel.
  • Roche’s Tecentriq hits trouble with NICE in bladder cancer pharmaphorum
    August 04, 2017
    NICE has said Roche’s cancer immunotherapy Tecentriq (atezolizumab) should not receive regular NHS funding as a treatment for bladder cancer in first draft guidance...

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service